Abbott Laboratories (Pakistan) Limited Overview
Pro stress-test →Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948, principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products. The company operates across Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
Strategic Profile
Pro stress-test →In 2024, revenue reached 68.18 billion PKR (up 22.90% YoY) with earnings of 5.23 billion PKR. The company operates through four segments: Pharmaceutical, Nutritional, Diagnostics, and Others, leveraging strong brand recognition with products like Similac, PediaSure, and Ensure in the nutritional category. The company trades at a P/E ratio of 20x, below the pharmaceuticals industry average of 22.4x.
Competitive Landscape
Pro stress-test →Abbott Pakistan operates in a competitive South Asian pharmaceutical market dominated by established players. The company competes across multiple segments (pharma, nutrition, diagnostics) with international brand advantages and local market presence. The broader Pakistani pharmaceutical sector has shown strong growth momentum, though Abbott underperformed industry returns over the past year.
Industry Context
Abbott Laboratories (Pakistan) Limited operates in Pharmaceuticals & Healthcare (Branded Generics, Nutritional Products, Diagnostics).
Key facts
Founded: 1948 · Headquarters: Karachi, Pakistan · Employees: 1,410 · Revenue: 68.18B PKR (2024) · Market cap: 101.53B PKR